UNSPSC 51393404: Choline theophyllinate or oxtriphylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3K045XR58X. European Medicines Agency schedules Choline theophyllinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06220MIG. Choline theophyllinate generally arises in the molecular formula C7H7N4O2.C5H14NO.

The term CHOLINE THEOPHYLLINATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, no. 3 1962, list 4.) Choline theophyllinate or oxtriphylline bears US NLM identifiers UMLS ID C0055578 and NCI Concept Code C47645. SMILES: OCC[N](C)(C)C.O=C1N(C(=O)N(C2NC[NH]C12)C)C.

UNSPSC 51393404 Choline theophyllinate or oxtriphylline is a Commodity code whose recent state and local procurement activity bears no meaningful relationship to the code's pharmaceutical designation. The two opportunities posted in the source — Seminole County's procurement of naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's request for information on direct-to-manufacturer prescription programs — involve different active pharmaceutical ingredients and delivery models that do not align with choline theophyllinate or oxtriphylline specifically. State and local governments do purchase pharmaceuticals through standard procurement channels, but the code shows little relevant recent activity under its stated scope.

The mismatch between the code's nominal pharmaceutical scope and the actual solicitations suggests that state and local procurement officers either miscoded these opportunities or that the code itself sees minimal direct use for choline theophyllinate or oxtriphylline acquisitions in state and local health, emergency management, or pharmacy benefit contexts. Seminole County's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) targets naloxone and deactivation systems for quarterly delivery to the Seminole County Community Health Building, while the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) explores vendor capabilities for direct manufacturer-to-state pharmacy contracting — neither directly procures the product this Commodity code nominates. Without evidence of recent opportunities actually soliciting choline theophyllinate or oxtriphylline, the code presents limited near-term pursuit opportunity.